Invention Grant
- Patent Title: Compounds for use in treating depression and migraine
-
Application No.: US16765480Application Date: 2018-11-22
-
Publication No.: US11357767B2Publication Date: 2022-06-14
- Inventor: Johannes Albertus Maria Smeitink , Julien David Beyrath
- Applicant: Khondrion IP B.V.
- Applicant Address: NL Beuningen
- Assignee: Khondrion IP B.V.
- Current Assignee: Khondrion IP B.V.
- Current Assignee Address: NL Beuningen
- Agency: N.V. Nederlandsch Octrooibureau
- Priority: EP17203136 20171122
- International Application: PCT/EP2018/082143 WO 20181122
- International Announcement: WO2019/101825 WO 20190531
- Main IPC: A61K31/453
- IPC: A61K31/453 ; A61P25/24 ; A61P25/06 ; A61K9/00 ; A61K31/452 ; A61K45/06
Abstract:
The invention relates to amide-derivatives of 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid for use in a treatment for preventing or suppressing symptoms associated with mood disorders, headaches and migraine. The compounds of the invention can be used to treat any subject suffering from a mood disorder, headaches and/or migraine but can specifically be used to treat a mood disorder, headaches and/or migraine in patients suffering from a mitochondrial disease.
Public/Granted literature
- US20200289491A1 Novel compounds for use in treating depression and migraine Public/Granted day:2020-09-17
Information query
IPC分类:
